Health Logic Interactive Inc. (CHYPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 794.08 Thousand USD | 8.59% |
| 2022 | 731.28 Thousand USD | 37.05% |
| 2021 | 533.6 Thousand USD | -16.85% |
| 2020 | 641.74 Thousand USD | 156.24% |
| 2019 | 250.45 Thousand USD | -56.92% |
| 2018 | 581.33 Thousand CAD | 71.03% |
| 2017 | 339.9 Thousand CAD | 127.96% |
| 2016 | 149.1 Thousand CAD | 260.36% |
| 2015 | 41.37 Thousand CAD | 30.67% |
| 2014 | 31.66 Thousand CAD | -93.16% |
| 2013 | 462.9 Thousand CAD | 2507.79% |
| 2012 | 17.75 Thousand CAD | -14.36% |
| 2011 | 20.72 Thousand CAD | 57.19% |
| 2010 | 13.18 Thousand CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 785.16 Thousand USD | -1.12% |
| 2024 Q2 | 1.09 Million CAD | 39.16% |
| 2023 Q2 | 759.16 Thousand USD | 3.5% |
| 2023 Q1 | 733.52 Thousand USD | 0.31% |
| 2023 Q4 | 794.08 Thousand USD | 5.38% |
| 2023 FY | 794.08 Thousand USD | 8.59% |
| 2023 Q3 | 753.55 Thousand USD | -0.74% |
| 2022 FY | 731.28 Thousand USD | 37.05% |
| 2022 Q4 | 731.28 Thousand USD | 10.86% |
| 2022 Q2 | 670.58 Thousand CAD | 8.19% |
| 2022 Q3 | 659.63 Thousand USD | -1.63% |
| 2022 Q1 | 619.81 Thousand CAD | 16.16% |
| 2021 Q2 | 662.53 Thousand CAD | -42.01% |
| 2021 Q3 | 965.9 Thousand CAD | 45.79% |
| 2021 Q4 | 533.6 Thousand CAD | -44.76% |
| 2021 Q1 | 1.14 Million CAD | 39.73% |
| 2021 FY | 533.6 Thousand USD | -16.85% |
| 2020 Q3 | 564.08 Thousand CAD | 15.09% |
| 2020 FY | 641.74 Thousand USD | 156.24% |
| 2020 Q1 | 374.41 Thousand CAD | 15.29% |
| 2020 Q2 | 490.13 Thousand CAD | 30.91% |
| 2020 Q4 | 817.58 Thousand CAD | 44.94% |
| 2019 Q4 | 324.77 Thousand CAD | 0.0% |
| 2019 Q1 | - CAD | -100.0% |
| 2019 FY | 250.45 Thousand USD | -56.92% |
| 2018 Q1 | 443.18 Thousand CAD | 4.06% |
| 2018 FY | 581.33 Thousand CAD | 71.03% |
| 2018 Q4 | 793.98 Thousand CAD | 117.77% |
| 2018 Q3 | 364.6 Thousand CAD | 6.6% |
| 2018 Q2 | 342.04 Thousand CAD | -22.82% |
| 2017 Q2 | 287.38 Thousand CAD | 57.27% |
| 2017 Q1 | 182.72 Thousand CAD | -8.62% |
| 2017 FY | 339.9 Thousand CAD | 127.96% |
| 2017 Q4 | 425.87 Thousand CAD | 25.7% |
| 2017 Q3 | 338.79 Thousand CAD | 17.89% |
| 2016 FY | 149.1 Thousand CAD | 260.36% |
| 2016 Q2 | 97.06 Thousand CAD | -26.79% |
| 2016 Q3 | 132.02 Thousand CAD | 36.02% |
| 2016 Q4 | 199.96 Thousand CAD | 51.46% |
| 2016 Q1 | 132.58 Thousand CAD | 130.68% |
| 2015 Q1 | 26.77 Thousand CAD | -15.45% |
| 2015 FY | 41.37 Thousand CAD | 30.67% |
| 2015 Q4 | 57.47 Thousand CAD | 2.21% |
| 2015 Q3 | 56.23 Thousand CAD | 52.05% |
| 2015 Q2 | 36.98 Thousand CAD | 38.14% |
| 2014 FY | 31.66 Thousand CAD | -93.16% |
| 2014 Q4 | 31.66 Thousand CAD | -34.96% |
| 2014 Q3 | 48.68 Thousand CAD | -88.95% |
| 2014 Q2 | 440.69 Thousand CAD | -4.23% |
| 2014 Q1 | 460.16 Thousand CAD | -0.59% |
| 2013 Q1 | 20.09 Thousand CAD | 13.23% |
| 2013 Q2 | 34.38 Thousand CAD | 71.06% |
| 2013 Q3 | 434.46 Thousand CAD | 1163.68% |
| 2013 Q4 | 462.9 Thousand CAD | 6.55% |
| 2013 FY | 462.9 Thousand CAD | 2507.79% |
| 2012 Q2 | 51.94 Thousand CAD | 48.67% |
| 2012 Q1 | 34.94 Thousand CAD | 68.57% |
| 2012 FY | 17.75 Thousand CAD | -14.36% |
| 2012 Q3 | 13.95 Thousand CAD | -73.14% |
| 2012 Q4 | 17.75 Thousand CAD | 27.24% |
| 2011 Q1 | 46.37 Thousand CAD | 251.65% |
| 2011 Q4 | 20.72 Thousand CAD | -21.16% |
| 2011 FY | 20.72 Thousand CAD | 57.19% |
| 2011 Q2 | 68.18 Thousand CAD | 47.05% |
| 2011 Q3 | 26.29 Thousand CAD | -61.44% |
| 2010 Q3 | 858.00 CAD | 0.0% |
| 2010 Q4 | 13.18 Thousand CAD | 1436.95% |
| 2010 FY | 13.18 Thousand CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | 95.223% |
| IR-Med Inc. | 634 Thousand USD | -25.249% |
| Polarean Imaging plc | 2.58 Million USD | 69.228% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -17.187% |
| Avitar, Inc. | 11.59 Million USD | 93.151% |
| AVITA Medical, Inc. | 19.86 Million USD | 96.003% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 62.508% |
| Össur hf. | 688.8 Million USD | 99.885% |
| Zecotek Photonics Inc. | 5.86 Million USD | 86.469% |
| QHSLab, Inc. | 2.05 Million USD | 61.397% |
| Wellstar International, Inc. | 55.99 Million USD | 98.582% |
| Össur hf. | 688.8 Million USD | 99.885% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 95.062% |
| Escalon Medical Corp. | 2.94 Million USD | 73.067% |
| Aurora Spine Corporation | 6.65 Million USD | 88.065% |
| BrainsWay Ltd. | 15.31 Million USD | 94.815% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 86.793% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 98.268% |
| Vivos Inc. | 245 Thousand USD | -224.109% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.968% |
| Kelyniam Global, Inc. | 1.01 Million USD | 21.606% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -188.113% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 67.586% |
| Nanomix Corporation | 14.81 Million USD | 94.64% |
| Theraclion SA | 13.01 Million EUR | 93.899% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 84.503% |
| Positron Corporation | 2.02 Million USD | 60.805% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 78.071% |
| Lombard Medical, Inc. | 53.79 Million USD | 98.524% |
| ALR Technologies Inc. | 24.5 Million USD | 96.76% |
| Stratec SE | 271.97 Million USD | 99.708% |
| Vycor Medical, Inc. | 4.31 Million USD | 81.609% |
| Heart Tronics, Inc. | 1.09 Million USD | 27.467% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 66.335% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 85.5% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 98.789% |
| VMS Rehab Systems, Inc. | 201.36 USD | -394258.86% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 85.496% |
| Ingen Technologies, Inc. | 5.7 Million USD | 86.092% |
| Odyssey Group International, Inc. | 6.61 Million USD | 87.99% |
| United American Healthcare Corporation | 119 Thousand USD | -567.295% |
| ECGI Holdings, Inc. | 11.94 Million USD | 93.35% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 40.023% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 45.097% |
| Urologix, Inc. | 12.64 Million USD | 93.72% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 85.284% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 90.639% |
| SS Innovations International, Inc. | 11.18 Million USD | 92.898% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -51.142% |
| Smith & Nephew plc | 4.76 Billion USD | 99.983% |
| NIOX Group Plc | 9.8 Million USD | 91.899% |
| Fuse Medical, Inc. | 15.11 Million USD | 94.745% |
| Broncus Holding Corporation | 10.43 Million USD | 92.388% |
| Brain Scientific Inc. | 7.42 Million USD | 89.307% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 97.651% |